Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...

Sugar Land is getting deeper into the drug game, the legal kind. City officials signed off this week on a plan that will ...

Danaher Corporation’s DHR Biotechnology segment continues to be a major contributor to its growth. In the first quarter of ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.

DelveInsight's Oncology-Based In-Vivo CRO Market Insights report provides the current and forecast market analysis, ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised for growth in the coming quarters owing to its progress on its strategic priority to lead in important specialty testing areas, which are growth ...

First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening ...